NORTHCOTT JOHN 4
4 · NEKTAR THERAPEUTICS · Filed Dec 22, 2020
Insider Transaction Report
Form 4
NORTHCOTT JOHN
SVP & Chief Commercial Officer
Transactions
- Award
Common Stock
2020-12-18+28,550→ 228,550 total - Award
Stock Option
2020-12-18+51,000→ 51,000 totalExercise: $18.75Exp: 2028-12-17→ Common Stock (51,000 underlying)
Footnotes (2)
- [F1]This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. These RSUs vest over three years in substantially equal quarterly installments based on continued service.
- [F2]This stock option vests over four years in equal monthly installments based on continued service.